Skip to content

Implanta

Healthcare·Italy·Exited 2020·Held 6yr
Entry
2014
Hold
6yr
Exit
2020

Who owns Implanta?

Implanta was owned by Argos Wityu through Argos Fund VI (2015 vintage) from 2014 to 2020.

Hand-verified · updated 2026-06-10

Argos Wityu
Investor
Argos Wityu
Argos Fund VI · 2015 · Buyout

Key facts

HQItaly
SectorHealthcare
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2020
Track Implanta

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

About Implanta

Implanta, formerly known as Odonto Group, is a Milan-based dental services group that operates across public and private hospitals and clinics, principally in Northern Italy. The company offers a complete range of odontostomatological care, spanning hygiene, implantology, pedodontics, gnathology and orthodontics, delivered to hospital-class clinical standards that allow it to treat patients with critical co-morbidities. Its structure combines an in-house dental laboratory with a network of more than ten satellite companies located in Italy and Switzerland. According to company and investor disclosures, Implanta employs roughly 80 people and was founded in Milan in 1994.

Ownership journey

Implanta was founded in Milan in 1994 and built up over the following two decades into a conglomerate dental group operating inside hospitals and clinics, supported by its own laboratory and a cluster of satellite entities in Italy and Switzerland. In 2014 Argos Wityu invested in the company through its Argos Fund VI, in what the firm described as its first healthcare-services transaction and its eleventh deal in Italy. The sponsor held the business through the second half of the decade and exited in 2020 via a trade sale.

Under PE ownership

The 2014 investment was structured as growth capital to consolidate a complex, conglomerate group that combined a state-of-the-art in-house laboratory with more than ten satellite companies spread across Italy and Switzerland. Under Argos Wityu's ownership the platform continued to operate a full range of dental services, from hygiene through to implantology, positioned around hospital-class standards and the ability to handle clinically complex patients. The holding ran through to 2020, when the sponsor exited via a trade sale, closing a roughly six-year investment period.

Who could buy Implanta?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Implanta.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue